4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-22-008837
President and CEO sold 3,595 shares at $12.66 ($45,513)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Walker Neal President and CEO | 2022-02-09 | Sale | −3,595 | $12.66 | $45,513 | 1,239,387 | D: show line 1 in the form |
| Open-market sales · 3,595 sh · avg $12.66 · $45,513 | |||||||
Loading xslF345X03/doc4.xml…